Sana Klinikum Offenbach GmbH; Klinik für Gynäkologie & Geburtshilfe
Offenbach, Germany
Obstetrician-gynecologist in Offenbach, Hessen
Starkenburgring 66, 63069 Offenbach am Main
About Sana Klinikum Offenbach GmbH; Klinik für Gynäkologie & Geburtshilfe
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
11
Clinical Trials at Sana Klinikum Offenbach GmbH; Klinik für Gynäkologie & Geburtshilfe
During the past decade, Sana Klinikum Offenbach GmbH; Klinik für Gynäkologie & Geburtshilfe conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 8 clinical trials were completed, i.e. on
average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Compare Subcutaneous (SC) Versus Intravenous (IV) Administration of Herceptin (Trastuzumab) in Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Early Breast Cancer
2009-10-16
2017-01-24
Completed
596
AURELIA: A Study of Avastin (Bevacizumab) Added to Chemotherapy in Patients With Platinum-resistant Ovarian Cancer
2009-10-29
2014-07-09
Completed
361
A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer
2011-11-08
2028-11-30
Active, not recruiting
4,804
A Safety and Tolerability Study of Assisted and Self-Administered Subcutaneous (SC) Herceptin (Trastuzumab) as Adjuvant Therapy in Early Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer
2012-05-17
2020-02-19
Completed
2,577
Pertuzumab in Platinum-Resistant Low Human Epidermal Growth Factor Receptor 3 (HER3) Messenger Ribonucleic Acid (mRNA) Epithelial Ovarian Cancer (PENELOPE)
2012-10-22
2016-04-28
Completed
208
A Study of Trastuzumab Emtansine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer Who Have Received Prior Anti-HER2 And Chemotherapy-based Treatment
2012-11-27
2020-07-31
Completed
2,185
A Study of Trastuzumab Emtansine Versus Trastuzumab as Adjuvant Therapy in Patients With HER2-Positive Breast Cancer Who Have Residual Tumor in the Breast or Axillary Lymph Nodes Following Preoperative Therapy (KATHERINE)
2013-04-03
2025-04-03
Active, not recruiting
1,487
Phase IIIb Study to Evaluate the Safety and Tolerability of Herceptin SC With Perjeta and Docetaxel in Patients With HER2-positive Advanced Breast Cancer
2015-05-06
2019-02-22
Completed
418
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Sana Klinikum Offenbach GmbH; Klinik für Gynäkologie & Geburtshilfe"
#1 collaborator was "Breast International Group" with 2 trials as a collaborator, "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Frontier Science & Technology Research Foundation, Inc." with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "German Breast Group" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 7 trials.
Clinical Trials Conditions at Sana Klinikum Offenbach GmbH; Klinik für Gynäkologie & Geburtshilfe
According to Clinical.Site data, the most researched conditions in "Sana Klinikum Offenbach GmbH; Klinik für Gynäkologie & Geburtshilfe" are
"Breast Cancer" (6 trials), "Ovarian Cancer" (2 trials), "Breast Neoplasms" (1 trials), "Early Breast Cancer" (1 trials) and "Triple Negative Breast Cancer" (1 trials). Many other conditions were trialed in "Sana Klinikum Offenbach GmbH; Klinik für Gynäkologie & Geburtshilfe" in a lesser frequency.
Clinical Trials Intervention Types at Sana Klinikum Offenbach GmbH; Klinik für Gynäkologie & Geburtshilfe
Most popular intervention types in "Sana Klinikum Offenbach GmbH; Klinik für Gynäkologie & Geburtshilfe" are "Drug" (11 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Cyclophosphamide" (4 trials), "Docetaxel" (4 trials), "Paclitaxel" (3 trials), "Placebo" (3 trials) and "5-Fluorouracil" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Sana Klinikum Offenbach GmbH; Klinik für Gynäkologie & Geburtshilfe
The vast majority of trials in "Sana Klinikum Offenbach GmbH; Klinik für Gynäkologie & Geburtshilfe" are
7 trials for "All" genders and 4 trials for "Female" genders.
Clinical Trials Status at Sana Klinikum Offenbach GmbH; Klinik für Gynäkologie & Geburtshilfe
Currently, there are NaN active trials in "Sana Klinikum Offenbach GmbH; Klinik für Gynäkologie & Geburtshilfe".
undefined are not yet recruiting,
1 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in Sana Klinikum Offenbach GmbH; Klinik für Gynäkologie & Geburtshilfe,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Sana Klinikum Offenbach GmbH; Klinik für Gynäkologie & Geburtshilfe, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 11 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".